ECM
BCAB icon

ExodusPoint Capital Management’s BioAtla BCAB Stock Holding History

ExodusPoint Capital Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-320
Closed -$80K – 1943
2022
Q1 		$80K Buy
+320
New +$134K ﹤0.01% 2028
2021
Q1 		– Sell
-357
Closed -$608K – 2119
2020
Q4 		$608K Buy
+357
New +$597K 0.01% 1129

Other funds holding BCAB

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ExodusPoint Capital Management's BCAB Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of BioAtla (BCAB) in Q2 2022, closing a stake of 320 shares — an estimated $80K sold.

ExodusPoint Capital Management first reported a position in BCAB in Q4 2020 and held it in 2 quarters. The position peaked at $608K in Q4 2020. 76 funds tracked by Wall St. Rank hold BCAB as of Q2 2022.

  • ExodusPoint Capital Management reported no remaining BioAtla position as of Q2 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 320 BioAtla shares in Q2 2022, an estimated $80K.
  • ExodusPoint Capital Management first reported a position in BioAtla in Q4 2020 and held it in 2 quarters.
  • ExodusPoint Capital Management's BioAtla position peaked at $608K in Q4 2020.
  • 76 funds tracked by Wall St. Rank held BioAtla as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.